According to a market report by Lucintel, the future of the global liver cancer diagnostic market looks promising with opportunities in the hospitals & diagnostic laboratory, academic & research institute, and pharmaceutical & CRO laboratory markets. The global liver cancer diagnostic market is expected to reach an estimated $11 billion by 2030 from $8 billion in 2024, at a CAGR of 6.2% from 2024 to 2030. The major drivers for this market are rising number of incidence related to liver cancer and growing demand for rapid screening methods & point-of-care tests.
A more
than 150-page report to understand trends, opportunity and forecast in global liver
cancer diagnostic market to 2030 by test type (laboratory tests, imaging,
endoscopy, biopsy, and others), end use (hospitals & diagnostic
laboratories, academic & research institutes, and pharmaceutical & CRO
laboratories), and region (North America, Europe, Asia Pacific, and the Rest of
the World).
Lucintel
forecasts that laboratory test will remain the largest segment over the
forecast period due to its rising preference among general public because of
its precision and cost-effectiveness.
Within
this market, hospital and diagnostic laboratory will remain the largest segment
over the forecast period.
Download
sample by clicking on liver
cancer diagnostic market.
North
America is expected to witness highest growth over the forecast period due to
existence of robust healthcare settings, rising adoption of healthcare
insurance policies among the population, and presence of key players in the
region.
Abbott
Laboratories, F. Hoffmann-La Roche, Qiagen, Thermo Fisher Scientific, Siemens
Healthineers are the major suppliers in the liver cancer diagnostic market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost
visit Lucintel's Analytics
Dashboard.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Touchless Biometrics Solutions Market
Voice Biometrics System Market
Autonomous Vehicle ECU Comprehensive Market
No comments:
Post a Comment